Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)

Gynecologic Oncology

Volumn 42, Issue 3, 1991, Pages 265-272

  Brooks, Sandra E ^a   Timmerman, John ^a   Lau, Ching C ^a   Tsao, Sai Wah ^a   Knapp, Robert C ^a   Sheets, Ellen E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BUCLADESINE; BUTYRIC ACID; CA 125 ANTIGEN; CYTOKERATIN; RETINOIC ACID; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BUCLADESINE; BUTYRIC ACID; BUTYRIC ACIDS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; KERATIN; OSMOLAR CONCENTRATION; OVARIAN NEOPLASMS; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0025945603     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(91)90356-A     Document Type: Article

References (40)

1. A review of American Cancer Society estimates of cancer cases and death
2. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma
3. CA 125 serum levels correlated with second-look operations among ovarian cancer patients
4. Predictive value of CA 125 antigen in second look procedures for ovarian cancer
5. Tumour-associated antigen CA 125 in patients with ovarian cancer
6. Serum CA 125 levels in epithelial ovarian cancer: Relation with findings at second-look operations and their role in the detection of tumour recurrence
7. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas
8. Reactivity of a monoclonal antibody with human ovarian carcinoma
9. Tissue distribution of a coelomicepithelium related antigen recognized by the monoclonal antibody OC 125
10. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation
11. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
12. Modulation of cell growth by retinoids and their possible mechanisms of action
13. Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA production
14. Effect of polar organic compounds on leukemic cells: Butyrate-induced partial remission of acute myelogenous leukemia in a child
15. Cyclic AMP induces differentiation in vitro of human melanoma cell
16. Effect of sodium butyrate on carcinoembryonic antigen production by human adenocarcinoma cells in culture
17. Cell death: The significance of apoptosis
18. Keratin classes: Molecular markers for different types of epithelial differentiation
19. Correlations of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies
20. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study
21. Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay
22. Effects of sodium butyrate on human colonic adenocarcinoma cells
23. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
24. Characterization and properties of nine human ovarian adenocarcinoma cell lines
25. Cell cycle analysis of sodium butyrate and hydroxyurea, inducers of ectopic hormone production in HeLa cells
26. Modulation of ectopic secretion of human chorionic gonadotropin by cultured ovarian adenocarcinoma cells
27. r, 53,000 protein with induction of differentiation of human neuroblastoma cells
28. Preparation, staining and analysis by flow cytometry of peripheral blood leukocytes
29. RIA for detection of change in cell surface tumor antigen expression induced by interferon
30. The mesothelial keratins: A new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: Correlation of antigen expression with metastatic potential
33. Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas
34. Heterogeneity of antigen expression in advanced epithelial ovarian cancer
35. CA 125 production of gynecologic tumors in vitro and its modulation induced by dibutyryl cyclic adenosine monophosphate
36. Hormonal regulation of CA 125 tumor marker expression in human ovarian carcinoma cells: Inhibition of glucocorticoids
37. Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate retinoic acid catecholamines and histamines
38. Keratins as biochemical markers of epithelial differentiation
39. Biology of disease classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations
40. Effects of retinoic acid on morphological features and biological markers of a neoplastic human salivary intercalated duct cell line in culture